Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion

Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion

Retinal diseases can result in blindness and visual impairment. They represent a significant medical burden and adversely affect life expectancy. Recently, antibody- and nucleic acid-based pharmaceuticals have increasingly been used to treat retinal diseases, with improvement or cure as the goal; ho...

Full description

Saved in:
Bibliographic Details
Main Authors: Taishi Shiratori, Takaaki Ito, Anri Nishinaka, Ryosuke Matsumiya, Eriko Yamazoe, Hirofumi Takeuchi, Hideaki Hara, Kohei Tahara
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Molecules
Subjects:
retina
eye drop
drug delivery
thermoresponsive gel
retinal-vein occlusion
nucleic acid
Online Access:https://www.mdpi.com/1420-3049/30/12/2622
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1420-3049/30/12/2622

Similar Items